Key result
Chisel-1, a functionalized nanobody targeting the CaVβ1 SH3 domain, essentially eliminated current through CaVβ1-reconstituted CaV2.2 channels (-1.65 pA/pF vs -102.8 pA/pF for control).
Why the study?
Tools to post-translationally inhibit HVACCs based on CaVβ isoform were non-existent, and conventional gene knockout/shRNA methods are limited by subunit reshuffling and overlapping functions.
Absolute Event Rate: -1.65% vs -102.8%
p-value: p=3.82×10^-6
The development of Chisel-1 provides a novel genetically-encoded tool for the selective post-translational inhibition of CaVβ1-associated voltage-dependent calcium channels.
No immediate clinical implications; leaves open whether nanobody-based CaV2.2 modulation can be translated to native systems or therapy.
Ca 2+ influx through high-voltage-activated calcium channels (HVACCs) controls diverse cellular functions. A critical feature enabling a singular signal, Ca 2+ influx, to mediate disparate functions is diversity of HVACC pore-forming α 1 and auxiliary Ca V β 1 –Ca V β 4 subunits. Selective Ca V α 1 blockers have enabled deciphering their unique physiological roles. By contrast, the capacity to post-translationally inhibit HVACCs based on Ca V β isoform is non-existent. Conventional gene knockout/shRNA approaches do not adequately address this deficit owing to subunit reshuffling and partially overlapping functions of Ca V β isoforms. Here, we identify a nanobody (nb.E8) that selectively binds Ca V β 1 SH3 domain and inhibits Ca V β 1 -associated HVACCs by reducing channel surface density, decreasing open probability, and speeding inactivation. Functionalizing nb.E8 with Nedd4L HECT domain yielded Chisel-1 which eliminated current through Ca V β 1 -reconstituted Ca V 1/Ca V 2 and native Ca V 1.1 channels in skeletal muscle, strongly suppressed depolarization-evoked Ca 2+ influx and excitation-transcription coupling in hippocampal neurons, but was inert against Ca V β 2 -associated Ca V 1.2 in cardiomyocytes. The results introduce an original method for probing distinctive functions of ion channel auxiliary subunit isoforms, reveal additional dimensions of Ca V β 1 signaling in neurons, and describe a genetically-encoded HVACC inhibitor with unique properties.
No takes yet. Share an insight, caveat, or question.
Morgenstern et al. (2022) studied this question. Chisel-1 (nb.E8-HECTNedd4L) vs. CFP control was evaluated on Whole-cell peak current density (Jpeak) of CaV2.2 channels reconstituted with β1b (p=3.82×10^-6). Chisel-1, a functionalized nanobody targeting the CaVβ1 SH3 domain, essentially eliminated current through CaVβ1-reconstituted CaV2.2 channels (-1.65 pA/pF vs -102.8 pA/pF for control).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: